drugset / Trial / NCT00742469
Rifaximin for Prevention of Travellers' Diarrhea
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to determine if 600 mg of rifaximin, taken once a day for 14 days by healthy subjects, is safe and effective for the prevention of travellers' diarrhea compared to placebo.
Timeline
- Start
- 2005-06
- Primary completion
- 2005-09
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rifaximin | Other / unclassified | 600 mg | — |